Aridis Pharmaceuticals, Inc. - Common Stock (ARDS)

CUSIP: 040334104

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock
Shares outstanding
44,586,623
Total 13F shares
4,126,564
Share change
+242,661
Total reported value
$1,294,359
Price per share
$0.31
Number of holders
19
Value change
-$1,724,919
Number of buys
8
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 040334104?
CUSIP 040334104 identifies ARDS - Aridis Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q1 2023

As of 31 Mar 2023, Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,126,564 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, VANGUARD GROUP INC, Roumell Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, PRUDENTIAL FINANCIAL INC, ACADIAN ASSET MANAGEMENT LLC, NORTHERN TRUST CORP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 19 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.